Authored By: Sarah
11 Sep 2024

Latest News: Cardiac Pacemakers Market is expected to grow by a CAGR of 6.78% during 2024-2028; Trends and Forecasts to 2018

The Cardiac Pacemakers Market is expected to grow at a CAGR of 6.78% to reach USD 5154.4 million by 2028. In the evolving landscape of the global cardiac pacemakers market, there is a significant shift towards remote monitoring of patient health and pacemaker performance. Previously, pacemaker patients were required to attend regular in-person follow-up appointments to assess their device's functionality and overall health status. However, advancements in remote monitoring technology now enable doctors to evaluate pacemaker data and patient health remotely. Medical professionals can wirelessly access and analyze pacemaker data, allowing for timely identification and resolution of potential issues. In the event of a detected problem, the healthcare provider may communicate with the patient to arrange a visit or adjust the pacemaker settings remotely, thereby enhancing patient outcomes and reducing the need for frequent in-person consultations.

North America dominates the regional market because of The Cardiac Pacemakers Market represents a significant business opportunity for industry players, driven by the growing prevalence of cardiac diseases and an aging population. Advanced technologies, such as remote monitoring and miniaturized devices, are fueling market growth. Key players include Medtronic, Boston Scientific, and Abbott, who are investing in R&D to introduce innovative solutions and expand their market share. The market is expected to reach substantial growth in the forecast period.

There are various factors that drive the Cardiac Pacemakers Market market which are as following: In the context of global health trends, the aging population poses a significant challenge due to the increased prevalence of cardiovascular diseases (CVDs), including arrhythmias and heart failure. Unhealthy lifestyle choices, such as poor diet, inactivity, and obesity, exacerbate this issue. Consequently, the demand for medical devices, particularly cardiac pacemakers, is on the rise. These devices are essential for managing heartbeat and rhythm in patients diagnosed with arrhythmias or other cardiovascular disorders. The market for pacemakers experiences growth in correlation with the incidence of CVDs, particularly in developed nations, where an aging population and unhealthy lifestyle factors contribute to a higher incidence of these conditions.

Be the first one to get the industry updates. Request for a sample report

Cardiac Pacemakers Market Segmentation

Product Type (Implantable cardiac pacemakers, External cardiac pacemakers) Technology (Single-chamber cardiac pacemakers, Dual-chamber cardiac pacemakers, Bi-ventricular cardiac pacemakers) Geography (North America, Europe, Asia, Rest of World (ROW))

The market witnesses several challenges, which are as follows The aging population's escalating demand for cardiac pacemakers poses a substantial challenge for global healthcare systems. With an increasing number of individuals requiring pacemakers, there may be a scarcity of adequately trained medical professionals to perform the procedures and provide ongoing monitoring. This shortage could lead to prolonged wait times, potentially compromising patient outcomes and quality of life. Moreover, the strain on healthcare resources resulting from this shortage could result in increased healthcare costs, which could be financially burdensome for both patients and healthcare systems. To mitigate these issues, it is imperative to allocate additional funding towards healthcare infrastructure development, invest in professional development programs for healthcare workers, and adopt advanced technologies that can enhance patient care while reducing resource utilization.

Stay ahead of your competitors. Download the Free PDF report

Some of the key companies that have been profiled in the report include: 

  • Abbott Laboratories
  • Asahi Kasei Corp.
  • BIOTRONIK SE and Co. KG
  • Boston Scientific Corp.
  • Cook Group Inc.
  • Edwards Lifesciences Corp.
  • Lepu Medical Technology Beijing Co. Ltd.
  • LivaNova PLC
  • Med Rel Inc.
  • MEDICO S.R.L.
  • Medtronic
  • MicroPort Scientific Corp.
  • OSCOR Inc.
  • Osypka Medical GmBH
  • Shree Pacetronix Ltd.
  • Uscom

Market Research Overview 

According to Technavio, the cardiac pacemakers market is a significant segment within the expansive global healthcare equipment industry. This sector encompasses organizations involved in the research and development (R&D) of diverse product categories, such as capital equipment, instruments, implants, accessories, and consumables. These products are integral to the diagnosis, monitoring, and treatment of various diseases. Technavio estimates the size of the global healthcare equipment market by aggregating the revenues generated by manufacturers of diagnostic equipment and devices spanning multiple therapy areas. The healthcare equipment sector encompasses the following segments: Devices, which comprise advanced, differentiated, and clinically validated data-driven devices. - The Cardiac Pacemakers Market is experiencing significant growth, fueled by the Growing prevalence of cardiovascular diseases. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Market Research Analysis

The global Cardiac Pacemakers Market is witnessing significant growth due to the increasing prevalence of heart disease, arrhythmias such as Atrial Fibrillation and Sick Sinus Syndrome, and postoperative complications like Heart Block. According to the American Heart Association, over 3 million Americans live with Atrial Fibrillation, and the number is projected to rise due to aging populations and rising incidences of CVDs (cardiovascular diseases). Biventricular pacemakers are increasingly being used to treat heart failure patients with reduced ejection fractions. Postoperative complications, including stroke, are a concern for pacemaker patients. Robust methodologies for implantation and follow-up care are essential to minimize risks. The healthcare system's focus on cost-effective care and medical tourism trends may impact market growth. MRI-safe pacemakers are gaining popularity due to their compatibility with magnetic resonance imaging (MRI). The patient pool for pacemakers includes those with arrhythmias, heart block, and other conditions requiring electrical impulses to regulate heartbeats. The market's growth is driven by factors such as increasing awareness, technological advancements, and the aging population. Electrodes and electrical impulses are the core components of pacemakers, which help regulate the heart's rhythm. The Lifespan Health System and BP (blood pressure) monitoring are additional features in modern pacemakers.


Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio